HYALO4 Control cream - Cation-active surfactant dressing
Access comprehensive regulatory information for HYALO4 Control cream - Cation-active surfactant dressing in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Ainscorp Pty Ltd, manufactured by Fidia Farmaceutici SPA in Italy. The device registration started on January 19, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
For the management of skin lesions, especially those at high risk of infection. In particular, it is intended to cover acute and chronic wounds (first and second degree burns, vascular and metabolic ulcers and pressure sores) and to provide a moist microbe-free wound environment. Hyalo4 Control can be used on non-infected wounds to help in preventing infection and, following successful treatment of infected wounds, to help prevent the reoccurrence of infection.